73Information to be given before prescribing substance

73 Information to be given before prescribing substance

73 Information to be given before prescribing substance

(1) This section applies if—

(a) a patient has made an administration decision, and

(b) the Board has issued a voluntary assisted dying substance authority in relation to the patient.

(2) The patient’s coordinating practitioner must, if the patient has made a self-administration decision, before prescribing a voluntary assisted dying substance for the patient, inform the patient, in writing, of the following—

(a) the Schedule 4 poison or Schedule 8 poison, or combination of poisons, constituting the substance,

(b) that the patient is not under an obligation to obtain the substance,

(c) that the patient is not under an obligation to self-administer the substance,

(d) how to dispense the substance,

(e) that the substance must be stored—

(i) in a locked box that complies with the requirements stated in section 79, and

(ii) otherwise in accordance with the information provided by the authorised supplier who supplies the substance,

(f) how to prepare and self-administer the substance,

(g) the method by which the substance will be self-administered,

(h) the expected effects of self-administration of the substance,

(i) the period within which the patient is likely to die after self-administration of the substance,

(j) the potential risks of self-administration of the substance,

(k) that, if the patient decides not to self administer the substance, the patient’s contact person must give the substance to an authorised disposer for disposal,

(l) that, if the patient dies, the patient’s contact person must give any unused or remaining substance to an authorised disposer for disposal.

(3) The coordinating practitioner for a patient who has made a practitioner administration decision must, before prescribing a voluntary assisted dying substance for the patient, inform the patient, in writing, of the following—